Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147
Title:
Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147
Author:
Huang, Jocelin Nair, Suresh G. Mahoney, Michelle R. Nelson, Garth D. Shields, Anthony F. Chan, Emily Goldberg, Richard M. Gill, Sharlene Kahlenberg, Morton S. Quesenberry, James T. Thibodeau, Stephen N. Smyrk, Thomas C. Grothey, Axel Sinicrope, Frank A. Webb, Thomas A. Farr Jr., Gist H. Pockaj, Barbara A. Berenberg, Jeffrey L. Mooney, Margaret Sargent, Daniel J. Alberts, Steven R.